

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 5.97876192 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.69545479 |
| 3 | keratan sulfate catabolic process (GO:0042340) | 5.49407777 |
| 4 | cell aggregation (GO:0098743) | 5.03100029 |
| 5 | cartilage condensation (GO:0001502) | 5.03100029 |
| 6 | response to peptidoglycan (GO:0032494) | 4.88974141 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.88341679 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.88341679 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.88341679 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.88341679 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.88341679 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.88341679 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.68412236 |
| 14 | negative regulation of cell killing (GO:0031342) | 4.68412236 |
| 15 | cellular extravasation (GO:0045123) | 4.63468401 |
| 16 | negative regulation of interleukin-12 production (GO:0032695) | 4.56809155 |
| 17 | neutrophil activation involved in immune response (GO:0002283) | 4.52376246 |
| 18 | * chondrocyte development (GO:0002063) | 4.46477668 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.40200007 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.25119482 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.07797657 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06986426 |
| 23 | collagen fibril organization (GO:0030199) | 4.04391572 |
| 24 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.03722321 |
| 25 | regulation of gamma-delta T cell activation (GO:0046643) | 4.03245483 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 3.94012412 |
| 27 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.92467745 |
| 28 | detection of other organism (GO:0098543) | 3.91029196 |
| 29 | response to muramyl dipeptide (GO:0032495) | 3.87262734 |
| 30 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.84599345 |
| 31 | locomotory exploration behavior (GO:0035641) | 3.82322701 |
| 32 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.73903378 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.70763650 |
| 34 | regulation of mast cell degranulation (GO:0043304) | 3.64182262 |
| 35 | germinal center formation (GO:0002467) | 3.63317480 |
| 36 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.62261240 |
| 37 | positive regulation of B cell differentiation (GO:0045579) | 3.60797192 |
| 38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.60432475 |
| 39 | detection of external biotic stimulus (GO:0098581) | 3.60341952 |
| 40 | immunoglobulin mediated immune response (GO:0016064) | 3.58215917 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.58185042 |
| 42 | Golgi transport vesicle coating (GO:0048200) | 3.57448143 |
| 43 | COPI coating of Golgi vesicle (GO:0048205) | 3.57448143 |
| 44 | detection of bacterium (GO:0016045) | 3.56442220 |
| 45 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.54474452 |
| 46 | positive regulation of extracellular matrix organization (GO:1903055) | 3.54357889 |
| 47 | positive regulation of mast cell activation (GO:0033005) | 3.54191954 |
| 48 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.53850486 |
| 49 | leukocyte aggregation (GO:0070486) | 3.47772470 |
| 50 | * chondroitin sulfate biosynthetic process (GO:0030206) | 3.43406680 |
| 51 | myeloid cell activation involved in immune response (GO:0002275) | 3.42141157 |
| 52 | regulation of leukocyte degranulation (GO:0043300) | 3.39939922 |
| 53 | granulocyte activation (GO:0036230) | 3.38829400 |
| 54 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.37015847 |
| 55 | respiratory burst (GO:0045730) | 3.36351181 |
| 56 | protein retention in ER lumen (GO:0006621) | 3.35519841 |
| 57 | neutrophil activation (GO:0042119) | 3.34580141 |
| 58 | response to host immune response (GO:0052572) | 3.33853766 |
| 59 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.33853766 |
| 60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.32805329 |
| 61 | macrophage activation (GO:0042116) | 3.26145576 |
| 62 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25988195 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 3.24967720 |
| 64 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.24967720 |
| 65 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.24435724 |
| 66 | microglial cell activation (GO:0001774) | 3.23327905 |
| 67 | B cell receptor signaling pathway (GO:0050853) | 3.19142186 |
| 68 | detection of biotic stimulus (GO:0009595) | 3.18296243 |
| 69 | negative regulation of T cell mediated immunity (GO:0002710) | 3.17918085 |
| 70 | regulation of mast cell activation (GO:0033003) | 3.16360875 |
| 71 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.12514019 |
| 72 | T-helper 1 type immune response (GO:0042088) | 3.11223155 |
| 73 | chondroitin sulfate catabolic process (GO:0030207) | 3.10448822 |
| 74 | response to host (GO:0075136) | 3.10342808 |
| 75 | response to host defenses (GO:0052200) | 3.10342808 |
| 76 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.10342808 |
| 77 | chondrocyte proliferation (GO:0035988) | 3.07438698 |
| 78 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.06366665 |
| 79 | dermatan sulfate biosynthetic process (GO:0030208) | 3.05658664 |
| 80 | neutrophil mediated immunity (GO:0002446) | 3.04973114 |
| 81 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.03969019 |
| 82 | regulation of B cell differentiation (GO:0045577) | 3.03447680 |
| 83 | positive regulation of leukocyte degranulation (GO:0043302) | 3.03135331 |
| 84 | positive thymic T cell selection (GO:0045059) | 3.00736470 |
| 85 | T cell migration (GO:0072678) | 3.00697264 |
| 86 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.00120513 |
| 87 | replacement ossification (GO:0036075) | 2.99908776 |
| 88 | endochondral ossification (GO:0001958) | 2.99908776 |
| 89 | response to protozoan (GO:0001562) | 2.99166343 |
| 90 | response to interleukin-15 (GO:0070672) | 2.98174613 |
| 91 | defense response to protozoan (GO:0042832) | 2.97971111 |
| 92 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96359747 |
| 93 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.91480145 |
| 94 | dermatan sulfate metabolic process (GO:0030205) | 2.91335312 |
| 95 | negative thymic T cell selection (GO:0045060) | 2.89727548 |
| 96 | proteoglycan metabolic process (GO:0006029) | 2.89128714 |
| 97 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.88271597 |
| 98 | collagen catabolic process (GO:0030574) | 2.88251900 |
| 99 | cellular response to type I interferon (GO:0071357) | 2.86962197 |
| 100 | type I interferon signaling pathway (GO:0060337) | 2.86962197 |
| 101 | positive regulation of p38MAPK cascade (GO:1900745) | 2.86823398 |
| 102 | regulation of tolerance induction (GO:0002643) | 2.86785516 |
| 103 | response to type I interferon (GO:0034340) | 2.84222364 |
| 104 | NIK/NF-kappaB signaling (GO:0038061) | 2.83469918 |
| 105 | regulation of T cell tolerance induction (GO:0002664) | 2.83302556 |
| 106 | cartilage development (GO:0051216) | 2.83183202 |
| 107 | leukocyte degranulation (GO:0043299) | 2.81153011 |
| 108 | myeloid dendritic cell activation (GO:0001773) | 2.80608775 |
| 109 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.79059785 |
| 110 | negative T cell selection (GO:0043383) | 2.78674425 |
| 111 | myeloid dendritic cell differentiation (GO:0043011) | 2.78360433 |
| 112 | negative regulation of interleukin-17 production (GO:0032700) | 2.77794128 |
| 113 | positive regulation of chondrocyte differentiation (GO:0032332) | 2.77702509 |
| 114 | regulation of regulated secretory pathway (GO:1903305) | 2.75581191 |
| 115 | regulation of extracellular matrix disassembly (GO:0010715) | 2.75475158 |
| 116 | myeloid leukocyte activation (GO:0002274) | 2.74911489 |
| 117 | neutrophil chemotaxis (GO:0030593) | 2.73626257 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.73517877 |
| 119 | positive regulation of interferon-alpha production (GO:0032727) | 2.73054094 |
| 120 | collagen metabolic process (GO:0032963) | 2.71670667 |
| 121 | tolerance induction (GO:0002507) | 2.71629939 |
| 122 | regulation of interferon-alpha production (GO:0032647) | 2.70927356 |
| 123 | keratan sulfate metabolic process (GO:0042339) | 2.70578258 |
| 124 | B cell mediated immunity (GO:0019724) | 2.67094358 |
| 125 | keratan sulfate biosynthetic process (GO:0018146) | 2.66929222 |
| 126 | hypotonic response (GO:0006971) | 2.66821156 |
| 127 | protein localization to endosome (GO:0036010) | 2.66164769 |
| 128 | neutrophil migration (GO:1990266) | 2.66083893 |
| 129 | multicellular organismal catabolic process (GO:0044243) | 2.58374221 |
| 130 | negative regulation of bone resorption (GO:0045779) | 2.58143901 |
| 131 | chondrocyte differentiation (GO:0002062) | 2.56348454 |
| 132 | exploration behavior (GO:0035640) | 2.55975240 |
| 133 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.53626903 |
| 134 | proline transport (GO:0015824) | 2.51729281 |
| 135 | negative regulation of bone remodeling (GO:0046851) | 2.50279206 |
| 136 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.50028223 |
| 137 | regulation of macrophage cytokine production (GO:0010935) | 2.49708579 |
| 138 | type B pancreatic cell development (GO:0003323) | 2.47291076 |
| 139 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.44565885 |
| 140 | peptidyl-proline hydroxylation (GO:0019511) | 2.42764753 |
| 141 | positive regulation of vesicle fusion (GO:0031340) | 2.42555343 |
| 142 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.41298036 |
| 143 | glycosaminoglycan catabolic process (GO:0006027) | 2.40965713 |
| 144 | negative regulation of fatty acid transport (GO:2000192) | 2.40680123 |
| 145 | endodermal cell differentiation (GO:0035987) | 2.40550570 |
| 146 | synaptic vesicle maturation (GO:0016188) | 2.40395074 |
| 147 | response to gravity (GO:0009629) | 2.40329043 |
| 148 | * chondroitin sulfate metabolic process (GO:0030204) | 2.37673142 |
| 149 | bone resorption (GO:0045453) | 2.37379608 |
| 150 | multicellular organismal metabolic process (GO:0044236) | 2.36967574 |
| 151 | endothelial cell morphogenesis (GO:0001886) | 2.35449117 |
| 152 | positive regulation of cartilage development (GO:0061036) | 2.35272560 |
| 153 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.34420233 |
| 154 | alanine transport (GO:0032328) | 2.33562635 |
| 155 | regulation of beta-amyloid formation (GO:1902003) | 2.32889691 |
| 156 | notochord development (GO:0030903) | 2.31996081 |
| 157 | negative regulation of tissue remodeling (GO:0034104) | 2.31550465 |
| 158 | extracellular matrix disassembly (GO:0022617) | 2.31298409 |
| 159 | positive regulation of macrophage cytokine production (GO:0060907) | 2.30368072 |
| 160 | negative regulation of gluconeogenesis (GO:0045721) | 2.30323086 |
| 161 | limb bud formation (GO:0060174) | 2.29883955 |
| 162 | sphingomyelin metabolic process (GO:0006684) | 2.28735976 |
| 163 | aminoglycan catabolic process (GO:0006026) | 2.24606523 |
| 164 | vesicle coating (GO:0006901) | 2.23974478 |
| 165 | positive regulation of astrocyte differentiation (GO:0048711) | 2.22821448 |
| 166 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.21792630 |
| 167 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21168932 |
| 168 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.20797799 |
| 169 | decidualization (GO:0046697) | 2.20520240 |
| 170 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.20337548 |
| 171 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.19307537 |
| 172 | positive regulation of axon extension (GO:0045773) | 2.19090974 |
| 173 | growth hormone receptor signaling pathway (GO:0060396) | 2.18561962 |
| 174 | regulation of synapse structural plasticity (GO:0051823) | 2.17688475 |
| 175 | regulation of fever generation (GO:0031620) | 2.15890159 |
| 176 | negative regulation of bone mineralization (GO:0030502) | 2.11541260 |
| 177 | * glycosaminoglycan biosynthetic process (GO:0006024) | 2.11457083 |
| 178 | positive regulation of heat generation (GO:0031652) | 2.10314769 |
| 179 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.08457133 |
| 180 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.08183202 |
| 181 | glycoprotein metabolic process (GO:0009100) | 2.07776955 |
| 182 | regulation of chondrocyte differentiation (GO:0032330) | 2.07599064 |
| 183 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 2.07057819 |
| 184 | regulation of bone mineralization (GO:0030500) | 2.06353636 |
| 185 | * aminoglycan biosynthetic process (GO:0006023) | 2.06324397 |
| 186 | positive regulation of nuclease activity (GO:0032075) | 2.05993699 |
| 187 | stress fiber assembly (GO:0043149) | 2.05793391 |
| 188 | adenosine receptor signaling pathway (GO:0001973) | 2.04979125 |
| 189 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.03466516 |
| 190 | sodium ion export (GO:0071436) | 2.03291500 |
| 191 | cellular response to growth hormone stimulus (GO:0071378) | 2.03291452 |
| 192 | regulation of cartilage development (GO:0061035) | 2.02843412 |
| 193 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.02526458 |
| 194 | cellular response to vitamin D (GO:0071305) | 2.02252237 |
| 195 | response to vitamin D (GO:0033280) | 2.02081357 |
| 196 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.01940062 |
| 197 | * mucopolysaccharide metabolic process (GO:1903510) | 2.00710299 |
| 198 | negative regulation of biomineral tissue development (GO:0070168) | 2.00162361 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.04262206 |
| 2 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.59034713 |
| 3 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.08657735 |
| 4 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.08212229 |
| 5 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.93926311 |
| 6 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.82628910 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.71103867 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.67893242 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.57403216 |
| 10 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.53216763 |
| 11 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42199212 |
| 12 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.38133074 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35799568 |
| 14 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.34679968 |
| 15 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.29905388 |
| 16 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.26953588 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.26277666 |
| 18 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23665424 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.22260989 |
| 20 | * MYB_26560356_Chip-Seq_TH2_Human | 2.17573893 |
| 21 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13699834 |
| 22 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09398414 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.06442533 |
| 24 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03782264 |
| 25 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.03760931 |
| 26 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.00316355 |
| 27 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97608709 |
| 28 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.96146584 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.93286950 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.93263113 |
| 31 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.93263113 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.90751948 |
| 33 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.90232067 |
| 34 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86280795 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.84039071 |
| 36 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.83877247 |
| 37 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81638239 |
| 38 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.76896052 |
| 39 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.76304937 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.75988106 |
| 41 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.73571136 |
| 42 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72791952 |
| 43 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71573056 |
| 44 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70578439 |
| 45 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.68787260 |
| 46 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.68495561 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.66310712 |
| 48 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.66185524 |
| 49 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.63507269 |
| 50 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.60749615 |
| 51 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.60022896 |
| 52 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.59361197 |
| 53 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.57824718 |
| 54 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.57085453 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56787484 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56782870 |
| 57 | * MAF_26560356_Chip-Seq_TH2_Human | 1.54996739 |
| 58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.54490709 |
| 59 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.52845888 |
| 60 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.51630917 |
| 61 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.50228119 |
| 62 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.50114175 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.49651455 |
| 64 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49195156 |
| 65 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.47149097 |
| 66 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.45781642 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.45495133 |
| 68 | CJUN_26792858_Chip-Seq_BT549_Human | 1.44458938 |
| 69 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.43745270 |
| 70 | RXR_22108803_ChIP-Seq_LS180_Human | 1.42454755 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.39396944 |
| 72 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.39173351 |
| 73 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.38792250 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.38308714 |
| 75 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37870218 |
| 76 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.37183100 |
| 77 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.37107638 |
| 78 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.34354060 |
| 79 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.33930306 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.33023082 |
| 81 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31182132 |
| 82 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31157522 |
| 83 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.29320999 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.29301863 |
| 85 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.28458313 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27616635 |
| 87 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.26453223 |
| 88 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.25867975 |
| 89 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.25867975 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25070588 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24883816 |
| 92 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24782581 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.24742922 |
| 94 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24714867 |
| 95 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.24577872 |
| 96 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.24523442 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23410815 |
| 98 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.23160069 |
| 99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23134640 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21964513 |
| 101 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21895061 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19922682 |
| 103 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19619517 |
| 104 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19370791 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.17435316 |
| 106 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.17013922 |
| 107 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.16046284 |
| 108 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.15359337 |
| 109 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13955214 |
| 110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13859503 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13756986 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13677848 |
| 113 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13236812 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12973634 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12796427 |
| 116 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.11813361 |
| 117 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11366916 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11311960 |
| 119 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.09980901 |
| 120 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.09842579 |
| 121 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09280369 |
| 122 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.09143027 |
| 123 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.08125589 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06967296 |
| 125 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06728235 |
| 126 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06692392 |
| 127 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.05917110 |
| 128 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03518057 |
| 129 | GATA3_26560356_Chip-Seq_TH2_Human | 1.03276284 |
| 130 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03118691 |
| 131 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02753162 |
| 132 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02475280 |
| 133 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01491319 |
| 134 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.01328738 |
| 135 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.00711447 |
| 136 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99521444 |
| 137 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.99499034 |
| 138 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.99267511 |
| 139 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99065577 |
| 140 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.98974953 |
| 141 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.98479384 |
| 142 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98261861 |
| 143 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98135886 |
| 144 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97466957 |
| 145 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.95933179 |
| 146 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.94521569 |
| 147 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93897662 |
| 148 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.93761048 |
| 149 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.93520014 |
| 150 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93275574 |
| 151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.92870729 |
| 152 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92156890 |
| 153 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91568809 |
| 154 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91241527 |
| 155 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.90839043 |
| 156 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90092988 |
| 157 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89371142 |
| 158 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87763592 |
| 159 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87297398 |
| 160 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86304468 |
| 161 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86192338 |
| 162 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.85627506 |
| 163 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.85320579 |
| 164 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.84535195 |
| 165 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84460207 |
| 166 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.84396849 |
| 167 | SPI1_23127762_ChIP-Seq_K562_Human | 0.84163471 |
| 168 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83772099 |
| 169 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.83611907 |
| 170 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.82500672 |
| 171 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78567177 |
| 172 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.77308562 |
| 173 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75824134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009780_abnormal_chondrocyte_physiolo | 4.29970379 |
| 2 | MP0003724_increased_susceptibility_to | 3.52287532 |
| 3 | MP0002909_abnormal_adrenal_gland | 3.23935590 |
| 4 | MP0002933_joint_inflammation | 3.22760872 |
| 5 | MP0005503_abnormal_tendon_morphology | 3.09787738 |
| 6 | MP0004134_abnormal_chest_morphology | 2.93435923 |
| 7 | MP0005671_abnormal_response_to | 2.75764399 |
| 8 | MP0002877_abnormal_melanocyte_morpholog | 2.74666807 |
| 9 | MP0002282_abnormal_trachea_morphology | 2.68911633 |
| 10 | MP0004859_abnormal_synaptic_plasticity | 2.64454468 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.62337696 |
| 12 | MP0006082_CNS_inflammation | 2.59545099 |
| 13 | MP0005025_abnormal_response_to | 2.56792940 |
| 14 | MP0003303_peritoneal_inflammation | 2.52520314 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.50460666 |
| 16 | MP0009785_altered_susceptibility_to | 2.47280377 |
| 17 | MP0002896_abnormal_bone_mineralization | 2.45500227 |
| 18 | * MP0000163_abnormal_cartilage_morphology | 2.45465997 |
| 19 | MP0001800_abnormal_humoral_immune | 2.45062766 |
| 20 | MP0003191_abnormal_cellular_cholesterol | 2.41413514 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.39221156 |
| 22 | MP0002089_abnormal_postnatal_growth/wei | 2.34539723 |
| 23 | MP0002723_abnormal_immune_serum | 2.32578518 |
| 24 | MP0002420_abnormal_adaptive_immunity | 2.26446631 |
| 25 | MP0001299_abnormal_eye_distance/ | 2.25174620 |
| 26 | MP0001819_abnormal_immune_cell | 2.24384371 |
| 27 | MP0001533_abnormal_skeleton_physiology | 2.23219735 |
| 28 | * MP0002115_abnormal_skeleton_extremities | 2.22689222 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 2.20234291 |
| 30 | MP0005464_abnormal_platelet_physiology | 2.19373442 |
| 31 | * MP0009250_abnormal_appendicular_skeleto | 2.15812354 |
| 32 | MP0004858_abnormal_nervous_system | 2.13151192 |
| 33 | MP0005451_abnormal_body_composition | 2.12112413 |
| 34 | MP0003283_abnormal_digestive_organ | 2.08606399 |
| 35 | MP0002405_respiratory_system_inflammati | 1.96867727 |
| 36 | MP0003172_abnormal_lysosome_physiology | 1.94778607 |
| 37 | MP0003763_abnormal_thymus_physiology | 1.94644628 |
| 38 | MP0002998_abnormal_bone_remodeling | 1.92662770 |
| 39 | MP0004947_skin_inflammation | 1.90579644 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.89286280 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.89286280 |
| 42 | * MP0002113_abnormal_skeleton_development | 1.86966288 |
| 43 | MP0005390_skeleton_phenotype | 1.84426755 |
| 44 | MP0003279_aneurysm | 1.80335033 |
| 45 | MP0003091_abnormal_cell_migration | 1.79650104 |
| 46 | MP0003300_gastrointestinal_ulcer | 1.77025458 |
| 47 | MP0002398_abnormal_bone_marrow | 1.76556258 |
| 48 | MP0008260_abnormal_autophagy | 1.74618224 |
| 49 | MP0000716_abnormal_immune_system | 1.73508476 |
| 50 | MP0003646_muscle_fatigue | 1.69756847 |
| 51 | MP0005508_abnormal_skeleton_morphology | 1.69650104 |
| 52 | MP0005076_abnormal_cell_differentiation | 1.69063531 |
| 53 | MP0009840_abnormal_foam_cell | 1.68846077 |
| 54 | MP0001853_heart_inflammation | 1.67922643 |
| 55 | MP0003656_abnormal_erythrocyte_physiolo | 1.66809387 |
| 56 | MP0003795_abnormal_bone_structure | 1.66807939 |
| 57 | MP0003828_pulmonary_edema | 1.66452985 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.65088089 |
| 59 | MP0009333_abnormal_splenocyte_physiolog | 1.64762181 |
| 60 | MP0003436_decreased_susceptibility_to | 1.63464473 |
| 61 | MP0003075_altered_response_to | 1.63352380 |
| 62 | MP0001958_emphysema | 1.62886608 |
| 63 | MP0009764_decreased_sensitivity_to | 1.56583142 |
| 64 | MP0000569_abnormal_digit_pigmentation | 1.55333307 |
| 65 | MP0010155_abnormal_intestine_physiology | 1.55309044 |
| 66 | MP0001270_distended_abdomen | 1.55190739 |
| 67 | MP0005623_abnormal_meninges_morphology | 1.50438706 |
| 68 | MP0004510_myositis | 1.49873121 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.48074195 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.45367046 |
| 71 | MP0002722_abnormal_immune_system | 1.45068899 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.44537542 |
| 73 | MP0002429_abnormal_blood_cell | 1.41621863 |
| 74 | MP0000858_altered_metastatic_potential | 1.41616665 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.39150978 |
| 76 | MP0001542_abnormal_bone_strength | 1.37062998 |
| 77 | MP0003566_abnormal_cell_adhesion | 1.36711973 |
| 78 | MP0008469_abnormal_protein_level | 1.35886431 |
| 79 | MP0005164_abnormal_response_to | 1.29450749 |
| 80 | MP0003690_abnormal_glial_cell | 1.27095394 |
| 81 | MP0009384_cardiac_valve_regurgitation | 1.25635940 |
| 82 | MP0003045_fibrosis | 1.25330381 |
| 83 | MP0001348_abnormal_lacrimal_gland | 1.24782794 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.22869393 |
| 85 | * MP0002109_abnormal_limb_morphology | 1.21418484 |
| 86 | MP0000685_abnormal_immune_system | 1.20988815 |
| 87 | MP0002254_reproductive_system_inflammat | 1.19177966 |
| 88 | MP0003635_abnormal_synaptic_transmissio | 1.14809497 |
| 89 | MP0001851_eye_inflammation | 1.12006999 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 1.11466669 |
| 91 | MP0000013_abnormal_adipose_tissue | 1.09305047 |
| 92 | MP0004381_abnormal_hair_follicle | 1.08539916 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 1.08096613 |
| 94 | MP0002163_abnormal_gland_morphology | 1.07939701 |
| 95 | * MP0002116_abnormal_craniofacial_bone | 1.04735325 |
| 96 | MP0003183_abnormal_peptide_metabolism | 1.03265845 |
| 97 | MP0000015_abnormal_ear_pigmentation | 1.00734998 |
| 98 | MP0003329_amyloid_beta_deposits | 1.00498308 |
| 99 | MP0004272_abnormal_basement_membrane | 1.00356735 |
| 100 | MP0000343_altered_response_to | 0.97926823 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.97586332 |
| 102 | MP0002063_abnormal_learning/memory/cond | 0.97151849 |
| 103 | MP0003705_abnormal_hypodermis_morpholog | 0.95911614 |
| 104 | MP0004270_analgesia | 0.95660583 |
| 105 | MP0003448_altered_tumor_morphology | 0.93905477 |
| 106 | MP0002735_abnormal_chemical_nociception | 0.93781862 |
| 107 | MP0008004_abnormal_stomach_pH | 0.92453786 |
| 108 | MP0003866_abnormal_defecation | 0.92204416 |
| 109 | MP0000678_abnormal_parathyroid_gland | 0.91911440 |
| 110 | MP0005387_immune_system_phenotype | 0.91134681 |
| 111 | MP0001790_abnormal_immune_system | 0.91134681 |
| 112 | MP0009763_increased_sensitivity_to | 0.88384410 |
| 113 | MP0003755_abnormal_palate_morphology | 0.85603017 |
| 114 | MP0010386_abnormal_urinary_bladder | 0.85425132 |
| 115 | MP0009278_abnormal_bone_marrow | 0.83845518 |
| 116 | MP0002419_abnormal_innate_immunity | 0.83340429 |
| 117 | MP0005379_endocrine/exocrine_gland_phen | 0.82216931 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.82080867 |
| 119 | MP0005166_decreased_susceptibility_to | 0.80838402 |
| 120 | MP0005023_abnormal_wound_healing | 0.80683191 |
| 121 | MP0000751_myopathy | 0.78380326 |
| 122 | MP0000428_abnormal_craniofacial_morphol | 0.78302736 |
| 123 | MP0000920_abnormal_myelination | 0.78103717 |
| 124 | MP0000371_diluted_coat_color | 0.77514855 |
| 125 | MP0005275_abnormal_skin_tensile | 0.76335996 |
| 126 | MP0006054_spinal_hemorrhage | 0.75421119 |
| 127 | MP0000249_abnormal_blood_vessel | 0.74874383 |
| 128 | MP0001873_stomach_inflammation | 0.74496857 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.74282601 |
| 130 | MP0001501_abnormal_sleep_pattern | 0.74254803 |
| 131 | MP0000432_abnormal_head_morphology | 0.74113460 |
| 132 | MP0002108_abnormal_muscle_morphology | 0.73766352 |
| 133 | MP0008961_abnormal_basal_metabolism | 0.73220940 |
| 134 | MP0005310_abnormal_salivary_gland | 0.72787757 |
| 135 | MP0009745_abnormal_behavioral_response | 0.72646282 |
| 136 | MP0005000_abnormal_immune_tolerance | 0.70496666 |
| 137 | MP0000733_abnormal_muscle_development | 0.69837767 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.69651576 |
| 139 | MP0002132_abnormal_respiratory_system | 0.69294116 |
| 140 | MP0002332_abnormal_exercise_endurance | 0.67707721 |
| 141 | MP0000534_abnormal_ureter_morphology | 0.67693233 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.65452083 |
| 143 | MP0003221_abnormal_cardiomyocyte_apopto | 0.64686034 |
| 144 | MP0001663_abnormal_digestive_system | 0.64623845 |
| 145 | MP0004883_abnormal_blood_vessel | 0.64541117 |
| 146 | MP0002006_tumorigenesis | 0.64222622 |
| 147 | MP0000049_abnormal_middle_ear | 0.64095055 |
| 148 | MP0002736_abnormal_nociception_after | 0.64077082 |
| 149 | MP0003941_abnormal_skin_development | 0.63819926 |
| 150 | MP0000767_abnormal_smooth_muscle | 0.63819009 |
| 151 | MP0008874_decreased_physiological_sensi | 0.63354505 |
| 152 | MP0005075_abnormal_melanosome_morpholog | 0.62149038 |
| 153 | MP0002064_seizures | 0.61548936 |
| 154 | MP0001968_abnormal_touch/_nociception | 0.61514893 |
| 155 | MP0004484_altered_response_of | 0.60566906 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.60157128 |
| 157 | MP0002734_abnormal_mechanical_nocicepti | 0.59927193 |
| 158 | MP0003935_abnormal_craniofacial_develop | 0.59904569 |
| 159 | MP0000490_abnormal_crypts_of | 0.59493813 |
| 160 | MP0003385_abnormal_body_wall | 0.58129058 |
| 161 | MP0000604_amyloidosis | 0.57987933 |
| 162 | MP0000681_abnormal_thyroid_gland | 0.57820974 |
| 163 | MP0002277_abnormal_respiratory_mucosa | 0.56676903 |
| 164 | MP0004185_abnormal_adipocyte_glucose | 0.54950948 |
| 165 | MP0003806_abnormal_nucleotide_metabolis | 0.54885648 |
| 166 | MP0005621_abnormal_cell_physiology | 0.51682703 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Epiphyseal dysplasia (HP:0002656) | 8.60468997 |
| 2 | Irregular epiphyses (HP:0010582) | 6.85510911 |
| 3 | Eczematoid dermatitis (HP:0000976) | 5.65666080 |
| 4 | Vitreoretinal degeneration (HP:0000655) | 5.65234721 |
| 5 | Hypoplastic ischia (HP:0003175) | 5.38940657 |
| 6 | Small epiphyses (HP:0010585) | 5.38355729 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 5.37607931 |
| 8 | Recurrent abscess formation (HP:0002722) | 5.25095172 |
| 9 | Abnormality of macrophages (HP:0004311) | 5.12692029 |
| 10 | Cupped ribs (HP:0000887) | 4.89116540 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.84936232 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.84936232 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 4.84936232 |
| 14 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 4.76397034 |
| 15 | Abnormality of the ischium (HP:0003174) | 4.75043769 |
| 16 | Flat capital femoral epiphysis (HP:0003370) | 4.66795978 |
| 17 | Delayed epiphyseal ossification (HP:0002663) | 4.53601445 |
| 18 | Abnormal tarsal ossification (HP:0008369) | 4.31179157 |
| 19 | Flat acetabular roof (HP:0003180) | 4.24773693 |
| 20 | Myositis (HP:0100614) | 4.13143318 |
| 21 | Genu varum (HP:0002970) | 3.98873552 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.97986800 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.92941840 |
| 24 | Orchitis (HP:0100796) | 3.92010596 |
| 25 | Flattened epiphyses (HP:0003071) | 3.89128519 |
| 26 | Neonatal short-limb short stature (HP:0008921) | 3.87598139 |
| 27 | Metaphyseal cupping (HP:0003021) | 3.87584333 |
| 28 | Cervical subluxation (HP:0003308) | 3.86097650 |
| 29 | Mild short stature (HP:0003502) | 3.77753571 |
| 30 | Stomatitis (HP:0010280) | 3.68962028 |
| 31 | Increased cerebral lipofuscin (HP:0011813) | 3.68596628 |
| 32 | Retrobulbar optic neuritis (HP:0100654) | 3.67843415 |
| 33 | Optic neuritis (HP:0100653) | 3.67843415 |
| 34 | Recurrent fungal infections (HP:0002841) | 3.66479217 |
| 35 | Abnormality of femoral epiphyses (HP:0006499) | 3.62525176 |
| 36 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 3.62525176 |
| 37 | Abnormality of the vertebral endplates (HP:0005106) | 3.61071211 |
| 38 | Osteoarthritis (HP:0002758) | 3.60346064 |
| 39 | Chronic obstructive pulmonary disease (HP:0006510) | 3.44657787 |
| 40 | Obstructive lung disease (HP:0006536) | 3.44657787 |
| 41 | Recurrent skin infections (HP:0001581) | 3.43007656 |
| 42 | Abnormal foot bone ossification (HP:0010675) | 3.34921885 |
| 43 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 3.28338113 |
| 44 | Absent frontal sinuses (HP:0002688) | 3.27051477 |
| 45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.21116374 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 3.20933882 |
| 47 | Irregular vertebral endplates (HP:0003301) | 3.17542716 |
| 48 | Meningitis (HP:0001287) | 3.15739055 |
| 49 | Recurrent viral infections (HP:0004429) | 3.15229808 |
| 50 | Short femoral neck (HP:0100864) | 3.11795271 |
| 51 | Dysostosis multiplex (HP:0000943) | 3.11170370 |
| 52 | Spontaneous hematomas (HP:0007420) | 3.11069669 |
| 53 | Gingivitis (HP:0000230) | 3.07779507 |
| 54 | Abnormality of the femoral head (HP:0003368) | 3.06335800 |
| 55 | T lymphocytopenia (HP:0005403) | 3.06289715 |
| 56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.02847792 |
| 57 | Recurrent cutaneous fungal infections (HP:0011370) | 3.02518108 |
| 58 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.02518108 |
| 59 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 3.01323128 |
| 60 | Absent epiphyses (HP:0010577) | 3.01323128 |
| 61 | Metaphyseal irregularity (HP:0003025) | 2.99463920 |
| 62 | Cellulitis (HP:0100658) | 2.99181294 |
| 63 | Thoracolumbar scoliosis (HP:0002944) | 2.98208550 |
| 64 | Hypoplasia of the odontoid process (HP:0003311) | 2.98006025 |
| 65 | Ovoid vertebral bodies (HP:0003300) | 2.97778026 |
| 66 | Loss of speech (HP:0002371) | 2.95068777 |
| 67 | Gastrointestinal infarctions (HP:0005244) | 2.93211857 |
| 68 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.91918561 |
| 69 | Exostoses (HP:0100777) | 2.90430807 |
| 70 | Enlarged epiphyses (HP:0010580) | 2.89678730 |
| 71 | Platyspondyly (HP:0000926) | 2.86742901 |
| 72 | Metaphyseal dysplasia (HP:0100255) | 2.86230530 |
| 73 | Protuberant abdomen (HP:0001538) | 2.84619866 |
| 74 | Autoimmune thrombocytopenia (HP:0001973) | 2.84234717 |
| 75 | Coxa vara (HP:0002812) | 2.82780951 |
| 76 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.80047464 |
| 77 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.79771456 |
| 78 | Urticaria (HP:0001025) | 2.79273119 |
| 79 | Vasculitis (HP:0002633) | 2.79084599 |
| 80 | Abnormality of T cell number (HP:0011839) | 2.77430014 |
| 81 | Beaking of vertebral bodies (HP:0004568) | 2.75693786 |
| 82 | Spinal cord compression (HP:0002176) | 2.75241389 |
| 83 | Abnormality of the pubic bones (HP:0003172) | 2.71563696 |
| 84 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.70570816 |
| 85 | Arthropathy (HP:0003040) | 2.69010327 |
| 86 | Keratoconjunctivitis sicca (HP:0001097) | 2.68953767 |
| 87 | Increased IgE level (HP:0003212) | 2.65625813 |
| 88 | Waddling gait (HP:0002515) | 2.62428009 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.61093948 |
| 90 | Disinhibition (HP:0000734) | 2.60351501 |
| 91 | Encephalitis (HP:0002383) | 2.59631528 |
| 92 | Abnormality of carpal bone ossification (HP:0006257) | 2.58053975 |
| 93 | Chest pain (HP:0100749) | 2.53741042 |
| 94 | Abnormality of the odontoid process (HP:0003310) | 2.53736008 |
| 95 | Disproportionate short-trunk short stature (HP:0003521) | 2.51929347 |
| 96 | Lumbar hyperlordosis (HP:0002938) | 2.50317577 |
| 97 | Abnormal vertebral ossification (HP:0100569) | 2.47893238 |
| 98 | Osteomyelitis (HP:0002754) | 2.47145098 |
| 99 | Barrel-shaped chest (HP:0001552) | 2.46877381 |
| 100 | Hemoptysis (HP:0002105) | 2.46020891 |
| 101 | Aplasia/hypoplasia of the femur (HP:0005613) | 2.45271877 |
| 102 | Pustule (HP:0200039) | 2.44578877 |
| 103 | Limited elbow extension (HP:0001377) | 2.44031769 |
| 104 | Myocardial infarction (HP:0001658) | 2.43919916 |
| 105 | Leukocytosis (HP:0001974) | 2.42354525 |
| 106 | Prolonged bleeding time (HP:0003010) | 2.41414975 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.40126445 |
| 108 | Radial bowing (HP:0002986) | 2.39955381 |
| 109 | Arterial thrombosis (HP:0004420) | 2.36191261 |
| 110 | Amyloidosis (HP:0011034) | 2.35457815 |
| 111 | Epistaxis (HP:0000421) | 2.34689053 |
| 112 | Systemic lupus erythematosus (HP:0002725) | 2.32470763 |
| 113 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.32398845 |
| 114 | Hepatosplenomegaly (HP:0001433) | 2.30630049 |
| 115 | Abnormality of the lumbar spine (HP:0100712) | 2.29150970 |
| 116 | Inflammation of the large intestine (HP:0002037) | 2.28412942 |
| 117 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28113802 |
| 118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28113802 |
| 119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28113802 |
| 120 | Granulocytopenia (HP:0001913) | 2.27999353 |
| 121 | Petechiae (HP:0000967) | 2.25944433 |
| 122 | Vertebral clefting (HP:0008428) | 2.25278820 |
| 123 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.24701041 |
| 124 | Limited hip movement (HP:0008800) | 2.24100972 |
| 125 | Mesomelia (HP:0003027) | 2.23986160 |
| 126 | Gastrointestinal inflammation (HP:0004386) | 2.23621103 |
| 127 | Slow saccadic eye movements (HP:0000514) | 2.21488914 |
| 128 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.21324997 |
| 129 | Abnormality of T cells (HP:0002843) | 2.20749964 |
| 130 | Mucopolysacchariduria (HP:0008155) | 2.20312993 |
| 131 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.20312993 |
| 132 | Interstitial pulmonary disease (HP:0006530) | 2.19855160 |
| 133 | Thin ribs (HP:0000883) | 2.18748204 |
| 134 | Colitis (HP:0002583) | 2.17806090 |
| 135 | Gingival bleeding (HP:0000225) | 2.17705427 |
| 136 | Abnormality of the frontal sinuses (HP:0002687) | 2.15944895 |
| 137 | Increased serum ferritin (HP:0003281) | 2.15474898 |
| 138 | Upper motor neuron abnormality (HP:0002127) | 2.14274371 |
| 139 | Neurofibrillary tangles (HP:0002185) | 2.12645900 |
| 140 | Purpura (HP:0000979) | 2.10162756 |
| 141 | Abnormal hand bone ossification (HP:0010660) | 2.09437770 |
| 142 | Autoimmune hemolytic anemia (HP:0001890) | 2.08872818 |
| 143 | Abnormal ossification of hand bones (HP:0005921) | 2.07740553 |
| 144 | Relative macrocephaly (HP:0004482) | 2.07551059 |
| 145 | Broad phalanx (HP:0006009) | 2.06352405 |
| 146 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.05965230 |
| 147 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.05785978 |
| 148 | Vertebral hypoplasia (HP:0008417) | 2.05603675 |
| 149 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.05603675 |
| 150 | Viral hepatitis (HP:0006562) | 2.05583708 |
| 151 | Broad long bones (HP:0005622) | 2.04406581 |
| 152 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.04301625 |
| 153 | Panhypogammaglobulinemia (HP:0003139) | 2.01894550 |
| 154 | Hematochezia (HP:0002573) | 2.00769468 |
| 155 | Broad thumb (HP:0011304) | 1.99529948 |
| 156 | Mixed hearing impairment (HP:0000410) | 1.98143684 |
| 157 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.97836463 |
| 158 | Genu valgum (HP:0002857) | 1.97801189 |
| 159 | Increased IgM level (HP:0003496) | 1.97468952 |
| 160 | Amaurosis fugax (HP:0100576) | 1.96768880 |
| 161 | Pulmonary embolism (HP:0002204) | 1.96198903 |
| 162 | Neuronal loss in central nervous system (HP:0002529) | 1.96114366 |
| 163 | Hip contracture (HP:0003273) | 1.95380285 |
| 164 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.95166229 |
| 165 | Genu recurvatum (HP:0002816) | 1.94862128 |
| 166 | Hypoplastic ilia (HP:0000946) | 1.94357233 |
| 167 | Stillbirth (HP:0003826) | 1.93954114 |
| 168 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.93716325 |
| 169 | Fatigue (HP:0012378) | 1.93129592 |
| 170 | Abnormality of proline metabolism (HP:0010907) | 1.92397506 |
| 171 | Hydroxyprolinuria (HP:0003080) | 1.92397506 |
| 172 | Thoracic kyphosis (HP:0002942) | 1.92117907 |
| 173 | Sepsis (HP:0100806) | 1.91614125 |
| 174 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 1.90757368 |
| 175 | Micromelia (HP:0002983) | 1.89477554 |
| 176 | Joint stiffness (HP:0001387) | 1.89471957 |
| 177 | Abnormality of the acetabulum (HP:0003170) | 1.89436628 |
| 178 | Agammaglobulinemia (HP:0004432) | 1.88552435 |
| 179 | Hypergammaglobulinemia (HP:0010702) | 1.87984989 |
| 180 | Glomerulopathy (HP:0100820) | 1.87862842 |
| 181 | Anorexia (HP:0002039) | 1.87600944 |
| 182 | Premature rupture of membranes (HP:0001788) | 1.87452962 |
| 183 | Episodic fever (HP:0001954) | 1.87121810 |
| 184 | Spondylolisthesis (HP:0003302) | 1.86017004 |
| 185 | Abnormality of iron homeostasis (HP:0011031) | 1.85569956 |
| 186 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.85255470 |
| 187 | Mutism (HP:0002300) | 1.85242282 |
| 188 | Premature loss of primary teeth (HP:0006323) | 1.85231941 |
| 189 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.82993838 |
| 190 | Subacute progressive viral hepatitis (HP:0006572) | 1.82893068 |
| 191 | Ulnar deviation of the wrist (HP:0003049) | 1.81080942 |
| 192 | Abnormality of incisor morphology (HP:0011063) | 1.80073480 |
| 193 | Ulnar bowing (HP:0003031) | 1.77045377 |
| 194 | Rhizomelia (HP:0008905) | 1.76084841 |
| 195 | Coxa valga (HP:0002673) | 1.75692329 |
| 196 | Flared metaphyses (HP:0003015) | 1.75691453 |
| 197 | Persistence of primary teeth (HP:0006335) | 1.75657447 |
| 198 | Severe short stature (HP:0003510) | 1.74288943 |
| 199 | Hand muscle atrophy (HP:0009130) | 1.72806117 |
| 200 | Short middle phalanx of finger (HP:0005819) | 1.71756171 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DDR2 | 5.31280471 |
| 2 | MAP3K3 | 3.59322696 |
| 3 | PRPF4B | 3.29983199 |
| 4 | MAP4K1 | 3.00581546 |
| 5 | TRIB3 | 2.93825337 |
| 6 | BLK | 2.91246443 |
| 7 | STK24 | 2.74310070 |
| 8 | MAP2K3 | 2.66258225 |
| 9 | TYK2 | 2.63161988 |
| 10 | IRAK4 | 2.59695311 |
| 11 | PRKD3 | 2.55843289 |
| 12 | RIPK4 | 2.43163190 |
| 13 | NTRK3 | 2.40649740 |
| 14 | CSK | 2.36272040 |
| 15 | IRAK3 | 2.33838484 |
| 16 | PDGFRA | 2.21249311 |
| 17 | ZAP70 | 2.13733180 |
| 18 | RIPK1 | 2.00777360 |
| 19 | MAP3K2 | 1.93427781 |
| 20 | ERBB3 | 1.92351585 |
| 21 | TAOK1 | 1.75735270 |
| 22 | FGFR3 | 1.74397631 |
| 23 | MATK | 1.68771937 |
| 24 | FGR | 1.64886703 |
| 25 | NTRK1 | 1.64491312 |
| 26 | IKBKE | 1.61550154 |
| 27 | SYK | 1.60730349 |
| 28 | CAMKK1 | 1.57467569 |
| 29 | PRKG2 | 1.56388621 |
| 30 | BTK | 1.55461042 |
| 31 | TXK | 1.52439960 |
| 32 | SIK1 | 1.51857321 |
| 33 | TAOK2 | 1.49139175 |
| 34 | MAP3K11 | 1.48149257 |
| 35 | TAOK3 | 1.41086367 |
| 36 | RET | 1.40962544 |
| 37 | PLK2 | 1.37956111 |
| 38 | MAP3K14 | 1.37338444 |
| 39 | MAP3K9 | 1.31540790 |
| 40 | PKN2 | 1.28148352 |
| 41 | GRK6 | 1.28106884 |
| 42 | PRKCH | 1.27786142 |
| 43 | CAMKK2 | 1.23339087 |
| 44 | LYN | 1.23015962 |
| 45 | NME2 | 1.22108309 |
| 46 | TBK1 | 1.21919533 |
| 47 | PDGFRB | 1.18011536 |
| 48 | STK3 | 1.17522813 |
| 49 | EPHA4 | 1.15596037 |
| 50 | KIT | 1.14783779 |
| 51 | DMPK | 1.14484076 |
| 52 | GRK7 | 1.13643264 |
| 53 | CSF1R | 1.13508160 |
| 54 | STK10 | 1.13075238 |
| 55 | JAK1 | 1.12346730 |
| 56 | SCYL2 | 1.10964200 |
| 57 | LCK | 1.10288962 |
| 58 | MARK3 | 1.09892931 |
| 59 | SIK2 | 1.09057997 |
| 60 | TNK2 | 1.07466263 |
| 61 | JAK3 | 1.05608706 |
| 62 | FRK | 1.01537509 |
| 63 | IRAK2 | 1.01107843 |
| 64 | BMX | 0.99934533 |
| 65 | CDK12 | 0.99739830 |
| 66 | STK38L | 0.99209180 |
| 67 | PTK6 | 0.97404613 |
| 68 | TRPM7 | 0.95317839 |
| 69 | MAP3K13 | 0.94961484 |
| 70 | ITK | 0.93978528 |
| 71 | IRAK1 | 0.93198427 |
| 72 | CHUK | 0.92595544 |
| 73 | ALK | 0.89703331 |
| 74 | MAP3K1 | 0.87919919 |
| 75 | SMG1 | 0.87821897 |
| 76 | KSR2 | 0.87676131 |
| 77 | PIM2 | 0.86686802 |
| 78 | PAK6 | 0.85999690 |
| 79 | PTK2 | 0.85252523 |
| 80 | NME1 | 0.85072198 |
| 81 | HIPK2 | 0.83353231 |
| 82 | SIK3 | 0.83096475 |
| 83 | MARK2 | 0.81170658 |
| 84 | TEC | 0.78111987 |
| 85 | IKBKB | 0.77587292 |
| 86 | KSR1 | 0.77011012 |
| 87 | YES1 | 0.76004275 |
| 88 | BMPR2 | 0.75603824 |
| 89 | TESK2 | 0.75573201 |
| 90 | ICK | 0.74797383 |
| 91 | MAP3K4 | 0.74369626 |
| 92 | EPHB1 | 0.74246849 |
| 93 | NEK6 | 0.73432671 |
| 94 | DAPK2 | 0.69689231 |
| 95 | CDC42BPA | 0.69629532 |
| 96 | ROCK1 | 0.69594556 |
| 97 | NEK9 | 0.69547441 |
| 98 | MINK1 | 0.69242392 |
| 99 | CDK5 | 0.68905386 |
| 100 | PAK3 | 0.67935762 |
| 101 | GSK3A | 0.66695222 |
| 102 | MAP3K6 | 0.66051300 |
| 103 | SGK3 | 0.65921711 |
| 104 | NTRK2 | 0.65465652 |
| 105 | CAMK1G | 0.64223539 |
| 106 | ERN1 | 0.63228365 |
| 107 | FES | 0.62715251 |
| 108 | MAPK7 | 0.62134633 |
| 109 | RPS6KL1 | 0.62134196 |
| 110 | RPS6KC1 | 0.62134196 |
| 111 | PIM1 | 0.61741195 |
| 112 | EPHA3 | 0.61439826 |
| 113 | LRRK2 | 0.60705852 |
| 114 | STK38 | 0.58396761 |
| 115 | MAP3K10 | 0.58333384 |
| 116 | MOS | 0.55201193 |
| 117 | PTK2B | 0.54962118 |
| 118 | CDK4 | 0.53645237 |
| 119 | SGK1 | 0.53598423 |
| 120 | IGF1R | 0.52769227 |
| 121 | TGFBR2 | 0.52209213 |
| 122 | MAP3K5 | 0.52190257 |
| 123 | TTN | 0.52167584 |
| 124 | CLK1 | 0.51910736 |
| 125 | PAK2 | 0.51673972 |
| 126 | RPS6KA2 | 0.50078883 |
| 127 | MARK1 | 0.49752854 |
| 128 | DYRK1A | 0.49730506 |
| 129 | HCK | 0.49641573 |
| 130 | FYN | 0.49008758 |
| 131 | MAPK12 | 0.48736023 |
| 132 | RPS6KA6 | 0.48663923 |
| 133 | NLK | 0.48457141 |
| 134 | PDK1 | 0.46865877 |
| 135 | MAP3K8 | 0.46345411 |
| 136 | RAF1 | 0.45879978 |
| 137 | STK11 | 0.43727438 |
| 138 | MAP2K7 | 0.43698034 |
| 139 | FGFR4 | 0.43396863 |
| 140 | PIK3CG | 0.43218954 |
| 141 | JAK2 | 0.43001245 |
| 142 | CDK6 | 0.40125680 |
| 143 | MAPKAPK2 | 0.39301424 |
| 144 | CAMK1D | 0.38101810 |
| 145 | PRKCQ | 0.37559883 |
| 146 | FGFR1 | 0.36210317 |
| 147 | FER | 0.35658124 |
| 148 | PDPK1 | 0.35273516 |
| 149 | EGFR | 0.35124016 |
| 150 | MST4 | 0.34833648 |
| 151 | SRC | 0.34753220 |
| 152 | PRKACG | 0.34377592 |
| 153 | INSR | 0.33018069 |
| 154 | MAPK11 | 0.33012837 |
| 155 | MAPK13 | 0.32393354 |
| 156 | SGK2 | 0.32274575 |
| 157 | FLT3 | 0.31908321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.41746512 |
| 2 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.38616100 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20985128 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.81941867 |
| 5 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.80521500 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.79331761 |
| 7 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.77506760 |
| 8 | Measles_Homo sapiens_hsa05162 | 1.65962385 |
| 9 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.63533423 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.59693662 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53704099 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.51708502 |
| 13 | Influenza A_Homo sapiens_hsa05164 | 1.51588101 |
| 14 | Asthma_Homo sapiens_hsa05310 | 1.51335877 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.49727167 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.49029457 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48185174 |
| 18 | Olfactory transduction_Homo sapiens_hsa04740 | 1.48122939 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46503666 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.36184911 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35092185 |
| 22 | Malaria_Homo sapiens_hsa05144 | 1.31353100 |
| 23 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.31205132 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.30016085 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28698605 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.26778418 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.26650071 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.26270389 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.25863484 |
| 30 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.25780712 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.23594080 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.22080184 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20374093 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.18258164 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.18215547 |
| 36 | Circadian entrainment_Homo sapiens_hsa04713 | 1.16699266 |
| 37 | Leishmaniasis_Homo sapiens_hsa05140 | 1.16179478 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.14952534 |
| 39 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13805081 |
| 40 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12627887 |
| 41 | Salivary secretion_Homo sapiens_hsa04970 | 1.11046085 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09838301 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.08835743 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.08792525 |
| 45 | Shigellosis_Homo sapiens_hsa05131 | 1.08439935 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08324214 |
| 47 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07924869 |
| 48 | Hepatitis C_Homo sapiens_hsa05160 | 1.07837452 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.07790983 |
| 50 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.06934557 |
| 51 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05452945 |
| 52 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03731964 |
| 53 | Allograft rejection_Homo sapiens_hsa05330 | 1.01946607 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00643111 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.00522481 |
| 56 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.99650665 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.96469648 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95955707 |
| 59 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95160591 |
| 60 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.94908995 |
| 61 | Morphine addiction_Homo sapiens_hsa05032 | 0.94210800 |
| 62 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.92686353 |
| 63 | Lysosome_Homo sapiens_hsa04142 | 0.92461183 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92408043 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.92299654 |
| 66 | Gap junction_Homo sapiens_hsa04540 | 0.92140283 |
| 67 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.91264638 |
| 68 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.90274796 |
| 69 | Renin secretion_Homo sapiens_hsa04924 | 0.89890917 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.89383894 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.89340032 |
| 72 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89036169 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.88528932 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88416933 |
| 75 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87609482 |
| 76 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.87319135 |
| 77 | Amoebiasis_Homo sapiens_hsa05146 | 0.86930073 |
| 78 | Tuberculosis_Homo sapiens_hsa05152 | 0.86555526 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.86449254 |
| 80 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.85390527 |
| 81 | GABAergic synapse_Homo sapiens_hsa04727 | 0.84986785 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83893996 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83068711 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82937053 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82828215 |
| 86 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.82800650 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.82454766 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79515179 |
| 89 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.79453834 |
| 90 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.79248971 |
| 91 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78779983 |
| 92 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78360455 |
| 93 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.77853599 |
| 94 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77634479 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.77245153 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76857332 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.76487138 |
| 98 | Hepatitis B_Homo sapiens_hsa05161 | 0.76446652 |
| 99 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.76341617 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.75710501 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75401795 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.75360427 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75342182 |
| 104 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74397099 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73977114 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.73764638 |
| 107 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.73395000 |
| 108 | Legionellosis_Homo sapiens_hsa05134 | 0.72740813 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72681434 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.71785023 |
| 111 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.71369244 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71359486 |
| 113 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71336428 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.71184903 |
| 115 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70716180 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.70201618 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.69193304 |
| 118 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.68543883 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67573747 |
| 120 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67154535 |
| 121 | Other glycan degradation_Homo sapiens_hsa00511 | 0.66982674 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.66809803 |
| 123 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66701671 |
| 124 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.66378413 |
| 125 | Melanogenesis_Homo sapiens_hsa04916 | 0.66165316 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65974763 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65772222 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65680582 |
| 129 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65636137 |
| 130 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.65617130 |
| 131 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.65302960 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.65267488 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64842419 |
| 134 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.62307982 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62022087 |
| 136 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61868350 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.60064070 |
| 138 | Colorectal cancer_Homo sapiens_hsa05210 | 0.59158120 |
| 139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.58984056 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.57895857 |
| 141 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.55757799 |
| 142 | Prostate cancer_Homo sapiens_hsa05215 | 0.55460058 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54549570 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51143656 |
| 145 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45744856 |
| 146 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44866887 |
| 147 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43091958 |
| 148 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.40091522 |

